Omvoh Approved for Crohn's; Fitbit Predicts IBD Flares; H. Pylori and Gastric Cancer

(MedPage Today) -- The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active Crohn's disease, drugmaker Eli Lilly announced; the first-in-class interleukin-23 antagonist was previously...